The new HIV prevention drug lenacapavir is beginning to reach communities in Zambia, offering new hope in the global fight against HIV. Administered just twice a year, the injectable medication has demonstrated near-complete effectiveness in preventing HIV infection and is being hailed as one of the most significant advances in HIV prevention in decades. As rollout expands across Africa, attention is turning to how quickly and broadly the drug can be made available to the communities most affected by HIV. Read more here.